Clinical Trial Update: A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating how Insulin 287 and semaglutide work in the body, both individually and in combination, in people with Type 2 diabetes; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin 287 (NNC0148-0287 C)
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED